ANNA KIIHNL: Open Payments
NPI 1346896123 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,238 in 74 payments from 20 companies in 2025. Trend: 2023 $460 · 2024 $1,113 · 2025 $1,238
Food & beverage: $1,238
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $322 |
| Mirum Pharmaceuticals, Inc. | 1 | $130 |
| Ardelyx, Inc. | 7 | $118 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $110 |
| Janssen Biotech, Inc. | 4 | $81 |
| GENZYME CORPORATION | 3 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Phathom Pharmaceuticals, Inc. | 4 | $43 |
| Boston Scientific Corporation | 2 | $43 |
| Madrigal Pharmaceuticals | 2 | $37 |
Products named: Livmarli, RINVOQ, IBSRELA, XIFAXAN, TREMFYA, DUPIXENT, LINZESS, MAVYRET.
Industry payments across TN — which companies pay providers there.
